About 10X Genomics
10X Genomics is a company based in Pleasanton (United States) founded in 2012.. 10X Genomics has raised $199.9 million across 7 funding rounds from investors including Fidelity Investments, SVB and SoftBank Group. The company has 1,310 employees as of December 31, 2024. 10X Genomics has completed 6 acquisitions, including CARTANA, Epinomics and ReadCoor. 10X Genomics operates in a competitive market with competitors including Mission Bio, Element Biosciences, Cellares, LUMICKS and Xcell Biosciences, among others.
- Headquarter Pleasanton, United States
- Employees 1310 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name 10X Genomics, Inc.
-
Annual Revenue
$610.78 M-1.28as on Dec 31, 2024
-
Net Profit
$-182.63 M28.41as on Dec 31, 2024
-
EBITDA
$-148.49 M6.17as on Dec 31, 2024
-
Total Equity Funding
$199.9 M (USD)
in 7 rounds
-
Latest Funding Round
$85 M (USD), Series D
Jan 07, 2019
-
Investors
Fidelity Investments
& 9 more
-
Employee Count
1310
as on Dec 31, 2024
-
Investments & Acquisitions
CARTANA
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of 10X Genomics
10X Genomics is a publicly listed company on the NASDAQ with ticker symbol TXG in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of 10X Genomics
10X Genomics has successfully raised a total of $199.9M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $85 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series D — $85.0M
-
First Round
First Round
(06 Nov 2012)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2019 | Amount | Series D - 10X Genomics | Valuation | Meritech , Wells Fargo | |
| Jan, 2019 | Amount | Grant - 10X Genomics | Valuation |
investors |
|
| Apr, 2018 | Amount | Debt – Venture - 10X Genomics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in 10X Genomics
10X Genomics has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, SVB and SoftBank Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward US-based companies.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in multiple sectors by Paladin Capital.
|
Founded Year | Domain | Location | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by 10X Genomics
10X Genomics has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include CARTANA, Epinomics and ReadCoor. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Scale Biosciences is a company developing single-cell library preparation kits for genomic, epigenomic, and transcriptomic analysis.
|
2020 | ||||
|
Antigens, peptides, and tetramers for research are supplied online.
|
2018 | ||||
|
Provider of gene expression mapping technology in brain tissue
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - 10X Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
10X Genomics Comparisons
Competitors of 10X Genomics
10X Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mission Bio, Element Biosciences, Cellares, LUMICKS and Xcell Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| domain | founded_year | HQ Location |
Benchtop DNA sequencers are developed for research and diagnostic uses.
|
|
| domain | founded_year | HQ Location |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| domain | founded_year | HQ Location |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
|
| domain | founded_year | HQ Location |
Cell culture analysis devices for cancer research are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on 10X Genomics
Frequently Asked Questions about 10X Genomics
When was 10X Genomics founded?
10X Genomics was founded in 2012.
Where is 10X Genomics located?
10X Genomics is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Is 10X Genomics a funded company?
10X Genomics is a funded company, having raised a total of $199.9M across 7 funding rounds to date. The company's 1st funding round was a Debt – Venture of $75M, raised on Nov 06, 2012.
How many employees does 10X Genomics have?
As of Dec 31, 2024, the latest employee count at 10X Genomics is 1,310.
What is the annual revenue of 10X Genomics?
Annual revenue of 10X Genomics is $610.78M as on Dec 31, 2024.
What does 10X Genomics do?
10X Genomics was founded in 2012 and is headquartered in Pleasanton, United States. Instrument systems for genomic research are developed, including the Chromium platform with reagents and consumables for preparing sequencing libraries compatible with Illumina systems. Software for sequence analysis is provided, along with services such as whole-genome sequencing and exome sequencing. Operations focus on partitioning cells or DNA fragments via GemCode technology to enable barcoded libraries.
Who are the top competitors of 10X Genomics?
10X Genomics's top competitors include Mission Bio, Element Biosciences and Cellares.
Is 10X Genomics publicly traded?
Yes, 10X Genomics is publicly traded on NASDAQ under the ticker symbol TXG.
How many acquisitions has 10X Genomics made?
Who are 10X Genomics's investors?
10X Genomics has 10 investors. Key investors include Fidelity Investments, SVB, SoftBank Group, Wells Fargo, and European Union.
What is 10X Genomics's ticker symbol?
The ticker symbol of 10X Genomics is TXG on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.